Concepedia
Statistics
Publications
20
Citations
997
H-Index
14
Active since
1994
Affiliations
Abbott Fund(Current)
Abbott (United Kingdom)
Alexion Pharmaceuticals (United States)
National University Hospital
The University of Texas at San Antonio Health Science Center
Rajendra Pradhan is an author at Abbott Fund specializing in pharmacology, medicine, and pharmacy.
Publications per year
1994–2024
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
Jong Wook Lee, Flore Sicre de Fontbrune, Lily Wong Lee Lee et al. · Blood · 2018 · 400 citations · Full text
Life Sciences, Immunology, Pharmacology +11
Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies
Chiung‐Ing Wong, Tong-San Koh, Ross A. Soo et al. · Journal of Clinical Oncology · 2009 · 83 citations · Full text
Pharmacy, Oncology, Pharmacology +17
Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer
Eng-Huat Tan, Glenwood Goss, Ravi Salgia et al. · Journal of Thoracic Oncology · 2011 · 66 citations
Medicine, Oncology, Pharmacology +8
Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis
Edward A. Ross, Jin Tian, Hanna E. Abboud et al. · American Journal of Nephrology · 2007 · 61 citations
Medicine, Nephrology, Pharmacotherapy +17
Comparison of the Gastrointestinal Absorption and Bioavailability of Fenofibrate and Fenofibric Acid in Humans
Tong Zhu, Jean‐Claude Ansquer, Maureen T. Kelly et al. · The Journal of Clinical Pharmacology · 2010 · 58 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
1–5 of 20